If you are not sure if the website you would like to visit is secure, you can verify it here. Enter the website address of the page and see parts of its content and the thumbnail images on this site. None (if any) dangerous scripts on the referenced page will be executed. Additionally, if the selected site contains subpages, you can verify it (review) in batches containing 5 pages.
favicon.ico: investors.bd.com/sec-filings/quarterly-reports - Quarterly Reports :: Becton, D.

site address: investors.bd.com/sec-filings/quarterly-reports redirected to: investors.bd.com/sec-filings/quarterly-reports

site title: Quarterly Reports :: Becton, Dickinson and Company (BDX)

Our opinion (on Friday 26 June 2026 12:11:35 UTC):

GREEN status (no comments) - no comments
After content analysis of this website we propose the following hashtags:



Meta tags:

Headings (most frequently used words):

quarterly, reports, sec, filings, forward, looking, statement, investors,

Text of the page (most frequently used words):
and (61), solutions (52), management (28), page (22), safety (16), #quarterly (14), diagnostic (14), form (12), center (12), the (11), report (11), surgery (10), patient (10), hypodermic (10), needle (10), syringe (10), drug (10), company (9), support (9), statements (9), section (9), overview (9), our (8), forward (8), looking (8), filings (8), medication (8), sepsis (8), integrated (8), original (8), equipment (8), manufacturing (8), oem (8), all (7), reports (7), other (6), events (6), sec (6), pursuant (6), asia (6), africa (6), north (6), united (6), about (6), customer (6), surgical (6), ambulatory (6), vascular (6), access (6), vam (6), microbiology (6), hazardous (6), accuracy (6), efficiency (6), clinical (6), are (5), news (5), investors (5), expectations (5), results (5), corporate (5), statement (4), risks (4), uncertainties (4), from (4), any (4), annual (4), with (4), financial (4), sections (4), board (4), login (4), south (4), middle (4), east (4), turkey (4), europe (4), america (4), states (4), canada (4), supplier (4), global (4), policies (4), process (4), device (4), distributor (4), pharmaceutical (4), lab (4), cervical (4), cancer (4), screening (4), portfolio (4), antimicrobial (4), resistance (4), targeted (4), temperature (4), accessibility (3), use (3), training (3), ethics (3), compliance (3), media (3), blogs (3), literature (3), for (3), cybersecurity (3), careers (3), email (3), such (3), business (3), information (3), assumptions (3), may (3), growth (3), product (3), development (3), directors (3), sustainability (3), faq (3), leadership (3), skip (3), privacy (2), website (2), contact (2), trademarks (2), becton (2), dickinson (2), 2026 (2), rss (2), rss_feed (2), contacts (2), alerts (2), based (2), current (2), involve (2), actual (2), could (2), materially (2), implied (2), that (2), differ (2), date (2), this (2), time (2), securities (2), analyst (2), similar (2), words (2), future (2), content (2), filing (2), view (2), accounting (2), governance (2), stock (2), data (2), info (2), southeast (2), 대한민국 (2), india (2), greater (2), australia (2), new (2), zealand (2), pacific (2), kingdom (2), schweiz (2), polska (2), österreich (2), nordics (2), nederland (2), italia (2), ישראל (2), france (2), españa (2), deutschland (2), česká (2), republika (2), belgië (2), belgique (2), colombia (2), chile (2), argentina (2), américa (2), latina (2), mexico (2), recognition (2), programs (2), procurement (2), doing (2), suppliers (2), recent (2), mergers (2), acquisitions (2), quality (2), guidelines (2), idea (2), submission (2), innovation (2), external (2), funding (2), opportunities (2), transparency (2), supply (2), chain (2), impact (2), healthy (2), workforce (2), communities (2), climate (2), change (2), unique (2), identifier (2), udi (2), list (2), distributors (2), helpful (2), resources (2), disclosure (2), bulletins (2), patches (2), trust (2), fluid (2), segments (2), learning (2), care (2), portal (2), guides (2), portals (2), knowledge (2), venous (2), technology (2), plastic (2), reconstructive (2), hernia (2), repair (2), pharmacy (2), laboratory (2), medical (2), manufacturer (2), delivery (2), systems (2), stone (2), clinician (2), administrator (2), products (2), your, choices, terms, notice, cookie, preferences, rights, reserved, logo, property, their, respective, owners, inclusion, engagement, electronic, instructions, recalls, field, actions, quick, links, follow, sitemap, account_tree, feed, contact_page, upon, number, vary, anticipated, described, projected, many, these, beyond, control, discussion, certain, factors, cause, see, latest, expressly, disclaims, undertaking, update, revise, set, forth, herein, reflect, circumstances, after, hereof, except, required, applicable, law, regulation, included, provided, through, webcasts, conference, calls, meetings, road, show, presentations, investor, conferences, newsletters, communications, contains, defined, under, federal, laws, ever, materialize, prove, incorrect, those, expressed, identified, plan, expect, believe, intend, will, anticipate, estimate, meaning, conjunction, among, things, discussions, operations, performance, including, volume, pricing, sales, earnings, per, share, cash, flows, regarding, strategy, regulatory, approvals, competitive, position, expenditures, reading, you, acknowledging, select, arrow_forward, next, pages, xbrl, description, 1994, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, year, type, reporting, internal, controls, auditing, matters, documents, dividends, split, history, coverage, historical, quote, chart, additional, credit, rating, proxy, executive, notices, innovates, calendar, press, releases, academy, footer, navigation, main, bdx,


Text of the page (random words):
quarterly reports becton dickinson and company bdx skip to main content skip to section navigation skip to footer products solutions administrator ambulatory surgery center solutions bd hypodermic needle and syringe solutions diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management surgical solutions targeted temperature management vascular access management vam clinician ambulatory surgery center solutions antimicrobial resistance bd original equipment manufacturing oem bd hypodermic needle and syringe solutions cervical cancer screening portfolio clinical and lab support diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management stone management surgical solutions targeted temperature management vascular access management vam distributor bd original equipment manufacturing oem bd hypodermic needle and syringe solutions drug development company drug delivery systems medical device manufacturer bd original equipment manufacturing oem laboratory antimicrobial resistance bd original equipment manufacturing oem cervical cancer screening portfolio clinical and lab support clinical microbiology diagnostic accuracy and efficiency integrated diagnostic solutions patient safety solutions pharmaceutical microbiology sepsis management pharmacy bd hypodermic needle and syringe solutions hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions pharmaceutical microbiology sepsis management vascular access management vam surgery ambulatory surgery center solutions bd hypodermic needle and syringe solutions hernia repair solutions patient safety solutions plastic and reconstructive surgery solutions surgical solutions venous technology knowledge center events literature training support customer portals medication management customer login customer care portal guides and faq s bd learning academy about bd our company about bd segments leadership board of directors ethics and compliance bd iv fluid support cybersecurity at bd about us trust center bulletins and patches disclosure process helpful resources distributors distributor list unique device identifier udi corporate sustainability climate change healthy workforce communities product impact supply chain transparency global external funding opportunities investors innovation at bd overview bd idea submission process news media and blogs policies guidelines and statements center quality recent mergers and acquisitions suppliers corporate policies and expectations doing business with bd global procurement supplier programs supplier recognition careers united states north america canada en canada fr mexico united states south america américa latina argentina chile colombia europe belgique belgië česká republika deutschland españa europe france ישראל italia nederland nordics österreich polska schweiz united kingdom middle east north africa turkey middle east north africa turkey south africa asia pacific australia new zealand 中国 greater asia india 日本 대한민국 southeast asia login products solutions administrator ambulatory surgery center solutions bd hypodermic needle and syringe solutions diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management surgical solutions targeted temperature management vascular access management vam clinician ambulatory surgery center solutions antimicrobial resistance bd original equipment manufacturing oem bd hypodermic needle and syringe solutions cervical cancer screening portfolio clinical and lab support diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management stone management surgical solutions targeted temperature management vascular access management vam distributor bd original equipment manufacturing oem bd hypodermic needle and syringe solutions drug development company drug delivery systems medical device manufacturer bd original equipment manufacturing oem laboratory antimicrobial resistance bd original equipment manufacturing oem cervical cancer screening portfolio clinical and lab support clinical microbiology diagnostic accuracy and efficiency integrated diagnostic solutions patient safety solutions pharmaceutical microbiology sepsis management pharmacy bd hypodermic needle and syringe solutions hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions pharmaceutical microbiology sepsis management vascular access management vam surgery ambulatory surgery center solutions bd hypodermic needle and syringe solutions hernia repair solutions patient safety solutions plastic and reconstructive surgery solutions surgical solutions venous technology knowledge center events literature training support customer portals medication management customer login customer care portal guides and faq s my bd learning about bd our company about bd segments leadership board of directors ethics and compliance bd iv fluid support cybersecurity at bd about us trust center bulletins and patches disclosure process helpful resources distributors distributor list unique device identifier udi corporate sustainability climate change healthy workforce communities product impact supply chain transparency global external funding opportunities investors innovation at bd overview bd idea submission process news media and blogs policies guidelines and statements center quality recent mergers and acquisitions suppliers corporate policies and expectations doing business with bd global procurement supplier programs supplier recognition careers united states north america canada en canada fr mexico united states south america américa latina argentina chile colombia europe belgique belgië česká republika deutschland españa europe france ישראל italia nederland nordics österreich polska schweiz united kingdom middle east north africa turkey middle east north africa turkey south africa asia pacific australia new zealand 中国 greater asia india 日本 대한민국 southeast asia login quarterly reports investors investors overview news events overview press releases ir calendar bd innovates email alerts other notices company info overview executive leadership annual reports and proxy contacts faq financial info overview financial results credit rating additional financial information stock data quote and chart historical data analyst coverage stock split history dividends sec filings overview all sec filings annual reports quarterly reports section 16 filings corporate sustainability governance overview board of directors governance documents contact the board reporting accounting internal accounting controls or auditing matters sec filings overview all sec filings annual reports quarterly reports section 16 filings filing type view all 10 q 10 q a year view all 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 sec filings date form description xbrl pages 05 07 26 10 q form 10 q quarterly report sections 13 or 15 d 60 02 09 26 10 q form 10 q quarterly report sections 13 or 15 d 50 08 07 25 10 q form 10 q quarterly report sections 13 or 15 d 73 05 01 25 10 q form 10 q quarterly report sections 13 or 15 d 55 02 06 25 10 q form 10 q quarterly report pursuant to section 13 or 15 d 46 08 01 24 10 q form 10 q quarterly report pursuant to section 13 or 15 d 48 05 02 24 10 q form 10 q quarterly report pursuant to section 13 or 15 d 45 02 01 24 10 q form 10 q quarterly report pursuant to section 13 or 15 d 44 08 03 23 10 q form 10 q quarterly report pursuant to section 13 or 15 d 50 05 04 23 10 q form 10 q quarterly report pursuant to section 13 or 15 d 47 rss_feed filing rss page 1 page 2 page 3 page 4 page 5 page 6 page 7 page 8 page 9 page 10 next page arrow_forward select a page page 1 page 2 page 3 page 4 page 5 page 6 page 7 page 8 page 9 page 10 by reading this content you are acknowledging our forward looking statement forward looking statement the information included on this website and other information provided from time to time through webcasts conference calls securities analyst meetings road show presentations investor conferences newsletters and similar events and communications contains forward looking statements as defined under federal securities laws based on current expectations and assumptions that involve risks and uncertainties if the risks or uncertainties ever materialize or the assumptions prove incorrect the results of bd may differ materially from those expressed or implied by such forward looking statements and assumptions forward looking statements may be identified by the use of words such as plan expect believe intend will may anticipate estimate and other words of similar meaning in conjunction with among other things discussions of future operations and financial performance including volume growth pricing sales and earnings per share growth and cash flows and statements regarding our strategy for growth future product development regulatory approvals competitive position and expenditures all such statements are based upon current expectations of bd and involve a number of business risks and uncertainties actual results could vary materially from anticipated results described implied or projected in any forward looking statement many of these risks and uncertainties are beyond the company s control for a discussion of certain factors that could cause our actual results to differ from our expectations in any forward looking statements see our latest annual report on form 10 k and other filings with the sec bd expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof except as required by applicable law or regulation email email alerts contact_page contacts rss_feed rss news feed account_tree sitemap accessibility accessibility statement follow us quick links recalls and field actions careers cybersecurity electronic instructions for use events investors inclusion and engagement literature news media and blogs our company ethics and compliance support training 2026 bd all rights reserved bd and the bd logo are trademarks of becton dickinson and company all other trademarks are the property of their respective owners contact us cookie preferences privacy notice terms of use website accessibility your privacy choices
Thumbnail images (randomly selected): * Images may be subject to copyright.GREEN status (no comments)
  • Becton, Dickinson and Com...
  • Country
  • Login Here
  • Linked In
  • Facebook
  • Instagram
  • Twitter
  • Youtube

Verified site has: 63 subpage(s). Do you want to verify them? Verify pages:

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-40 41-45 46-50
51-55 56-60 61-63


Top 50 hastags from of all verified websites.

Supplementary Information (add-on for SEO geeks)*- See more on header.verify-www.com

Header

HTTP/1.1 301 Moved Permanently
Server CloudFront
Date Fri, 26 Jun 2026 12:11:35 GMT
Content-Type text/html
Content-Length 167
Connection close
Location htt????/investors.bd.com/sec-filings/quarterly-reports
X-Cache Redirect from cloudfront
Via 1.1 ff7010ce6a43809a9e2df5e6441e868e.cloudfront.net (CloudFront)
X-Amz-Cf-Pop CDG55-P3
Alt-Svc h3= :443 ; ma=86400
X-Amz-Cf-Id tHu2crC2JqhguT_n4RiX_G3W52jkgHRGcPRxMXyXHVrr1JY2Mg06Hw==
HTTP/2 200
content-type text/html; charset=UTF-8
content-length 16752
date Fri, 26 Jun 2026 12:11:35 GMT
server Apache
x-frame-options SAMEORIGIN
strict-transport-security max-age=31536000;
x-xss-protection 1; mode=block
x-content-type-options nosniff
permissions-policy microphone=(), camera=(), geolocation=(), screen-wake-lock=()
referrer-policy strict-origin-when-cross-origin
content-security-policy default-src *.gstatic.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; script-src *.quotemedia.com *.google.com *.google-analytics.com *.googletagmanager.com *.gstatic.com *.hcaptcha.com *.browser-update.org hcaptcha.com dev-ir.stockpr.com www.youtube.com player.vimeo.com *.found.io *.cloudflare.com cloudflare.com cdn.cookielaw.org cookie-cdn.cookiepro.com *.onetrust.com pagead2.googlesyndication.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline ; connect-src *.quotemedia.com *.google.com *.google-analytics.com *.googletagmanager.com *.gstatic.com *.hcaptcha.com *.browser-update.org hcaptcha.com dev-ir.stockpr.com www.youtube.com player.vimeo.com *.found.io *.cloudflare.com cloudflare.com cdn.cookielaw.org cookie-cdn.cookiepro.com *.onetrust.com pagead2.googlesyndication.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline ; style-src fonts.googleapis.com *.gstatic.com *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com qmod.quotemedia.com static.c1.quotemedia.com *.cloudflare.com cloudflare.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline ; font-src cdnjs.cloudflare.com/ajax/libs/font-awesome/ fonts.googleapis.com *.gstatic.com static.c1.quotemedia.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; img-src i.ytimg.com qmod.quotemedia.com mma.prnewswire.com c212.net pixel.mathtag.com cdn.cookielaw.org www.googletagmanager.com edge.prnewswire.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; frame-src *.google.com youtube.com www.youtube.com youtube-nocookie.com www.youtube-nocookie.com vimeo.com player.vimeo.com *.hcaptcha.com hcaptcha.com *.googletagmanager.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; object-src *.gstatic.com ir.stockpr.com investors.bd.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net;
content-encoding gzip
vary Accept-Encoding
x-cache Miss from cloudfront
via 1.1 fd18baafadec0908f0d8ee9569158eaa.cloudfront.net (CloudFront)
x-amz-cf-pop CDG55-P3
alt-svc h3= :443 ; ma=86400
x-amz-cf-id 3nH6bhIIxwaROcG6vAaRi-w-uq6z4VFf95nUakhh9lhqa4iBtQZ8cA==

Meta Tags

title="Quarterly Reports :: Becton, Dickinson and Company (BDX)"
http-equiv="x-ua-compatible" content="ie=edge"
charset="utf-8"
property="og:url" content="htt????/investors.bd.com/sec-filings/quarterly-reports"
property="og:site_name" content="Becton, Dickinson and Company"
property="og:title" content="Quarterly Reports"
property="og:type" content="website"
property="og:image" content="htt????/d1io3yog0oux5.cloudfront.net/_6fb8852926d5a35783fe18e684fd003b/bd/db/2440/22365/social_image_resized.jpg"
name="twitter:card" content="summary_large_image"
name="viewport" content="initial-scale=1.0, width=device-width"
name="theme-color" content="#ffffff"

Load Info

page size16752
load time (s)0.442748
redirect count1
speed download37900
server IP 3.164.163.115
* all occurrences of the string "http://" have been changed to "htt???/"